Emma McErlean
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 5%
- Advancements in Transdermal Drug Delivery
Papers in
-
- RNA Interference and Gene Delivery 8
- Advanced biosensing and bioanalysis techniques 5
- Protein Degradation and Inhibitors 1
- Oncology 5
- Bone health and treatments 2
- Peptidase Inhibition and Analysis 2
- Co-authors
- Helen O. McCarthy (13 shared papers)Cian M. McCrudden (6 shared papers)Nicholas Dunne (8 shared papers)Tracy Robson (6 shared papers)Victoria Kett (5 shared papers)Grace Cole (3 shared papers)Joanne McCaffrey (3 shared papers)J.W. McBride (4 shared papers)
- Journals
- International Journal of Pharmaceutics (2 papers)Journal of Controlled Release (2 papers)Journal of Nanobiotechnology (2 papers)Drug Delivery and Translational Research (1 paper)Molecular Pharmaceutics (1 paper)
- Partner nations
- United KingdomIrelandJordan
In The Last Decade
Emma McErlean
14 papers receiving 429 citations
Peers
Comparison fields: 5 of 67
- Biomaterials 139
- Pharmaceutical Science 62
- Molecular Medicine 23
- Molecular Biology 229
- Dermatology 29
Countries citing papers authored by Emma McErlean
This map shows the geographic impact of Emma McErlean's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma McErlean with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma McErlean more than expected).
Fields of papers citing papers by Emma McErlean
This network shows the impact of papers produced by Emma McErlean. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma McErlean. The network helps show where Emma McErlean may publish in the future.
Co-authors
The 25 scholars most cited alongside Emma McErlean, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 121 | |
| 2 | 2019 | 84 | |
| 3 | 2020 | 42 | |
| 4 | 2020 | 38 | |
| 5 | 2018 | 32 | |
| 6 | 2016 | 32 | |
| 7 | 2016 | 25 | |
| 8 | 2021 | 20 | |
| 9 | 2021 | 9 | |
| 10 | 2024 | 8 | |
| 11 | 2021 | 6 | |
| 12 | 2021 | 6 | |
| 13 | 2025 | 3 | |
| 14 | 2024 | 3 |
About Emma McErlean
Emma McErlean is a scholar working on Molecular Biology, Oncology, Genetics, Biomaterials and Immunology, having authored 14 papers that have together received 429 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (8 papers), Advanced biosensing and bioanalysis techniques (5 papers), Virus-based gene therapy research (4 papers), Nanoplatforms for cancer theranostics (2 papers), Bone health and treatments (2 papers), Nanoparticle-Based Drug Delivery (2 papers), Peptidase Inhibition and Analysis (2 papers) and Protein Degradation and Inhibitors (1 paper). The work is most often cited by research in Biomaterials (139 citations), Pharmaceutical Science (62 citations), Molecular Medicine (23 citations), Molecular Biology (229 citations) and Dermatology (29 citations). Emma McErlean has collaborated with scholars based in United Kingdom, Ireland and Jordan. Frequent co-authors include Helen O. McCarthy, Cian M. McCrudden, Nicholas Dunne, Tracy Robson, Victoria Kett, Grace Cole, Joanne McCaffrey, J.W. McBride, Eoghan J. Mulholland and Jonathan A. Coulter. Their work appears in journals such as International Journal of Pharmaceutics, Journal of Controlled Release, Journal of Nanobiotechnology, Drug Delivery and Translational Research and Molecular Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.